Brief: SSY Group Says Group's SYN045 Tablets Obtained Approval From NMPA
03/04/2025 16:04
April 3 (Reuters) - SSY Group Ltd 2005.HK: GROUP'S SYN045 TABLETS OBTAINED APPROVAL FROM NMPA OF CHINA FOR ADDING 3 DIFFERENT SPECIFICATIONS FOR PHASE I CLINICAL TRIAL Further company coverage: 2005.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on SSY
See all newsBrief: SSY Group Receives NMPA China Approval For Sodium Cromoglicate Eye Drops 2%
Brief: SSY Group Obtains NMPA Approval For Nimodipine Oral Solution
Brief: SSY Group Appoints Wu Heng Yao As Executive Director
Brief: SSY Group Says Ziprasidone Mesilate Receives Registration Approval In China
Hong Kong's SSY Group H1 profit rises on infusion solutions growth